Statement of Ownership (sc 13g)
February 10 2022 - 5:04PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment
No. )*
Erasca, Inc.
(Name
of Issuer)
Common Stock par value $0.0001 per share
(Title
of Class of Securities)
29479A108
(CUSIP
Number)
December
31, 2021
(Date
of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided
in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however,
see the Notes).
CUSIP
No. 29479A108
|
13G
|
Page
2 of 16 Pages
|
1
|
|
NAMES
OF REPORTING PERSON(S)
ARCH Venture Fund X, L.P.
|
|
|
2
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐
|
3
|
|
SEC
USE ONLY
|
|
|
4
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
|
|
5
|
|
SOLE
VOTING POWER
0
|
|
6
|
|
SHARED
VOTING POWER
11,055,554
|
|
7
|
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
|
SHARED
DISPOSITIVE POWER
11,055,554
|
|
|
|
|
|
9
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,055,554
|
|
|
10
|
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐
|
11
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
|
|
|
12
|
|
TYPE
OF REPORTING PERSON
PN
|
|
|
CUSIP
No. 29479A108
|
13G
|
Page
3 of 16 Pages
|
1
|
|
NAMES
OF REPORTING PERSON(S)
ARCH Venture Fund X Overage, L.P.
|
|
|
2
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐
|
3
|
|
SEC
USE ONLY
|
|
|
4
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
|
|
5
|
|
SOLE
VOTING POWER
0
|
|
6
|
|
SHARED
VOTING POWER
11,055,554
|
|
7
|
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
|
SHARED
DISPOSITIVE POWER
11,055,554
|
|
|
|
|
|
9
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,055,554
|
|
|
10
|
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐
|
11
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
|
|
|
12
|
|
TYPE
OF REPORTING PERSON
PN
|
|
|
CUSIP
No. 29479A108
|
13G
|
Page
4 of 16 Pages
|
1
|
|
NAMES
OF REPORTING PERSON(S)
ARCH Venture Partners X, L.P.
|
|
|
2
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐
|
3
|
|
SEC
USE ONLY
|
|
|
4
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
|
|
5
|
|
SOLE
VOTING POWER
0
|
|
6
|
|
SHARED
VOTING POWER
11,055,554
|
|
7
|
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
|
SHARED
DISPOSITIVE POWER
11,055,554
|
|
|
|
|
|
9
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,055,554
|
|
|
10
|
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐
|
11
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
|
|
|
12
|
|
TYPE
OF REPORTING PERSON
PN
|
|
|
CUSIP
No. 29479A108
|
13G
|
Page
5 of 16 Pages
|
1
|
|
NAMES
OF REPORTING PERSON(S)
ARCH Venture Partners X Overage, L.P.
|
|
|
2
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐
|
3
|
|
SEC
USE ONLY
|
|
|
4
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
|
|
5
|
|
SOLE
VOTING POWER
0
|
|
6
|
|
SHARED
VOTING POWER
11,055,554
|
|
7
|
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
|
SHARED
DISPOSITIVE POWER
11,055,554
|
|
|
|
|
|
9
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,055,554
|
|
|
10
|
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐
|
11
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
|
|
|
12
|
|
TYPE
OF REPORTING PERSON
PN
|
|
|
CUSIP
No. 29479A108
|
13G
|
Page
6 of 16 Pages
|
1
|
|
NAMES
OF REPORTING PERSON(S)
ARCH Venture Partners X, LLC
|
|
|
2
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐
|
3
|
|
SEC
USE ONLY
|
|
|
4
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
Delaware
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
|
|
5
|
|
SOLE
VOTING POWER
0
|
|
6
|
|
SHARED
VOTING POWER
11,055,554
|
|
7
|
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
|
SHARED
DISPOSITIVE POWER
11,055,554
|
|
|
|
|
|
9
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,055,554
|
|
|
10
|
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐
|
11
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
|
|
|
12
|
|
TYPE
OF REPORTING PERSON
OO
|
|
|
CUSIP
No. 29479A108
|
13G
|
Page
7 of 16 Pages
|
1
|
|
NAMES
OF REPORTING PERSON(S)
Keith
Crandell
|
|
|
2
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐
|
3
|
|
SEC
USE ONLY
|
|
|
4
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United States of America
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
|
|
5
|
|
SOLE
VOTING POWER
0
|
|
6
|
|
SHARED
VOTING POWER
11,055,554
|
|
7
|
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
|
SHARED
DISPOSITIVE POWER
11,055,554
|
|
|
|
|
|
9
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,055,554
|
|
|
10
|
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐
|
11
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
|
|
|
12
|
|
TYPE
OF REPORTING PERSON
IN
|
|
|
CUSIP
No. 29479A108
|
13G
|
Page
8 of 16 Pages
|
1
|
|
NAMES
OF REPORTING PERSON(S)
Kristina Burow
|
|
|
2
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐
|
3
|
|
SEC
USE ONLY
|
|
|
4
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States of America
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
|
|
5
|
|
SOLE
VOTING POWER
0
|
|
6
|
|
SHARED
VOTING POWER
11,055,554
|
|
7
|
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
|
SHARED
DISPOSITIVE POWER
11,055,554
|
|
|
|
|
|
9
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,055,554
|
|
|
10
|
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐
|
11
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
|
|
|
12
|
|
TYPE
OF REPORTING PERSON
IN
|
|
|
CUSIP
No. 29479A108
|
13G
|
Page
9 of 16 Pages
|
1
|
|
NAMES
OF REPORTING PERSON(S)
Steven
Gillis
|
|
|
2
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐
|
3
|
|
SEC
USE ONLY
|
|
|
4
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United States of America
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
|
|
5
|
|
SOLE
VOTING POWER
0
|
|
6
|
|
SHARED
VOTING POWER
11,055,554
|
|
7
|
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
|
SHARED
DISPOSITIVE POWER
11,055,554
|
|
|
|
|
|
9
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,055,554
|
|
|
10
|
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐
|
11
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
|
|
|
12
|
|
TYPE
OF REPORTING PERSON
IN
|
|
|
CUSIP
No. 29479A108
|
13G
|
Page
10 of 16 Pages
|
1
|
|
NAMES
OF REPORTING PERSON(S)
Robert Nelsen
|
|
|
2
|
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
|
(a)
☐
(b)
☐
|
3
|
|
SEC
USE ONLY
|
|
|
4
|
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United States of America
|
|
|
|
|
|
|
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
|
|
5
|
|
SOLE
VOTING POWER
0
|
|
6
|
|
SHARED
VOTING POWER
11,055,554
|
|
7
|
|
SOLE
DISPOSITIVE POWER
0
|
|
8
|
|
SHARED
DISPOSITIVE POWER
11,055,554
|
|
|
|
|
|
9
|
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,055,554
|
|
|
10
|
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
|
☐
|
11
|
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
|
|
|
12
|
|
TYPE
OF REPORTING PERSON
IN
|
|
|
CUSIP
No. 29479A108
|
13G
|
Page
11 of 16 Pages
|
Item
1(a).
|
Name
of Issuer:
|
Erasca, Inc. (the “Issuer”).
Item
1(b).
|
Address
of Issuer's Principal Executive Offices:
|
10835 Road to the Cure, Suite 140, San Diego, CA 92121
Item
2(a).
|
Name
of Person Filing:
|
ARCH Venture Fund X, L.P. (“AVF X”); ARCH Venture Partners
X, L.P. (“AVP X LP”); ARCH Venture Partners X, LLC (“AVP X LLC”); ARCH Venture Fund X Overage, L.P. (“AVF
X Overage”); ARCH Venture Partners X Overage, L.P. (“AVF X Overage GP”) (collectively, the “Reporting Entities”
and individually, each a “Reporting Entity”); and Keith Crandell (“Crandell”), Robert Nelsen (“Nelsen”),
Kristina Burow (“Burow”) and Steven Gillis (“Gillis) (collectively, the “Investment Committee” and individually,
each a “Committee Member”). The Reporting Entities and the Committee Members collectively are referred to as the “Reporting
Persons”.
Item
2(b).
|
Address
of Principal Business Office or, if none, Residence:
|
8755 W. Higgins Avenue, Suite 1025, Chicago, IL 60631
Each of AVF X, AVF X LP, AVF X Overage and AVP X Overage GP, are limited
partnerships organized under the laws of the State of Delaware. AVP X LLC is a limited liability company organized under the laws of the
State of Delaware. Each Committee Member is a US citizen.
Item
2(d).
|
Title
of Class of Securities.
|
Common stock, par value $0.0001 per share.
29479A108
Item
3.
|
If
this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
|
Not
Applicable.
CUSIP
No. 29479A108
|
13G
|
Page
12 of 16 Pages
|
(a)
|
Amount beneficially owned:
AVF X is the record owner of 5,527,777 shares of Common Stock (the “AVF
X Shares”) as of December 31, 2021. AVP X LP, as the sole general partner of ARCH Venture Fund X, may be deemed to beneficially
own the AVF X Shares. AVF X Overage is the record owner of 5,527,777 shares of Common Stock (the “AVF X Overage Shares”; combined
with AVF X Shares, the “Record Shares”) as of December 31, 2021. AVP X Overage GP, as the sole general partner of AVF X Overage,
may be deemed to beneficially own the AVF X Overage Shares. AVP X LLC, as the sole general partner of AVP X LP and AVF X Overage LP, may
be deemed to beneficially own the Record Shares. As Committee Members of AVP X LLC, each Committee Member may also be deemed to share
the power to direct the disposition and vote of the Record Shares.
|
(b)
|
Percent of class:
See line 11 of the cover sheets. The percentages set forth on the cover
sheet for each Reporting Person is based upon 121,250,375 shares of common stock outstanding as of November 4, 2021 as reported on the
Issuer’s Form 10-Q as filed with the Securities and Exchange Commission on November 10, 2021.
|
|
|
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
Sole power to vote or to direct the vote:
See line 5 of the cover sheets.
|
|
|
|
|
(ii)
|
Shared power to vote or to direct the vote:
See line 6 of the cover sheets.
|
|
|
|
|
(iii)
|
Sole power to dispose or to direct the disposition:
See line 7 of the cover sheets.
|
|
|
|
|
(iv)
|
Shared power to dispose or to direct the disposition:
See line 8 of the cover sheets.
|
|
|
|
Each Reporting Person disclaims beneficial ownership of such shares of
Common Stock except for the shares, if any, such Reporting Person holds of record.
Item
5.
|
Ownership
of Five Percent or Less of a Class.
|
Not applicable.
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another Person.
|
Not applicable.
Item
7.
|
Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company.
|
Not
applicable.
Item
8.
|
Identification
and Classification of Members of the Group.
|
Not
applicable.
Item
9.
|
Notice
of Dissolution of Group.
|
Not
applicable.
Not
applicable.
CUSIP
No. 29479A108
|
13G
|
Page
13 of 16 Pages
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and correct.
Dated: February
10, 2022
ARCH
VENTURE FUND X, L.P.
By:
ARCH Venture Partners X, L.P.
its General
Partner
By: ARCH Venture Partners X, LLC
its General Partner
By:
*
Keith
Crandell
Managing
Director
ARCH VENTURE PARTNERS X, L.P.
By:
ARCH Venture Partners X, LLC
its General
Partner
By:
*
Keith Crandell
Managing Director
ARCH VENTURE PARTNERS X, LLC
By:
*
Keith Crandell
Managing Director
ARCH VENTURE FUND X OVERAGE, L.P.
By: ARCH
Venture Partners X Overage, L.P.
its General Partner
By: ARCH Venture
Partners X, LLC
its General Partner
By:
*
Keith
Crandell
Managing Director
ARCH VENTURE PARTNERS X OVERAGE, L.P.
By: ARCH
Venture Partners X, LLC
its General Partner
By:
*
Keith
Crandell
Managing Director
CUSIP
No. 29479A108
|
13G
|
Page
14 of 16 Pages
|
*
Keith Crandell
*
Robert Nelsen
*
Kristina Burow
*
Steven Gillis
* By: /s/
Mark McDonnell
Mark
McDonnell as
Attorney-in-Fact
* This Schedule 13G was executed by Mark McDonnell pursuant to a Power of
Attorney filed as Exhibit 24 and 24.1 to the Form 3 relating to the beneficial ownership of shares of Verve Therapeutics, Inc. by the
Reporting Persons filed with the Securities Exchange Commission on June 16, 2021 and incorporated herein in its entirety by reference.
CUSIP
No. 29479A108
|
13G
|
Page
15 of 16 Pages
|
Exhibit 1
AGREEMENT
Pursuant to Rule 13d-1-(k)(1) under the Securities Exchange Act of 1934,
the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to
the ownership by each of the undersigned of shares of stock of Erasca, Inc.
This Agreement may be executed in any number of counterparts, each
of which shall be deemed an original.
Dated:
February 10, 2022
ARCH
VENTURE FUND X, L.P.
By:
ARCH Venture Partners X, L.P.
its General
Partner
By: ARCH Venture Partners X, LLC
its General Partner
By:
*
Keith
Crandell
Managing
Director
ARCH VENTURE PARTNERS X, L.P.
By:
ARCH Venture Partners X, LLC
its General
Partner
By:
*
Keith Crandell
Managing Director
ARCH VENTURE PARTNERS X, LLC
By:
*
Keith Crandell
Managing Director
ARCH VENTURE FUND X OVERAGE, L.P.
By: ARCH
Venture Partners X Overage, L.P.
its General Partner
By: ARCH Venture
Partners X, LLC
its General Partner
By:
*
Keith
Crandell
Managing Director
ARCH VENTURE PARTNERS X OVERAGE, L.P.
By: ARCH
Venture Partners X, LLC
its General Partner
By:
*
Keith
Crandell
Managing Director
CUSIP
No. 29479A108
|
13G
|
Page
16 of 16 Pages
|
*
Keith Crandell
*
Robert Nelsen
*
Kristina Burow
*
Steven Gillis
* By: /s/
Mark McDonnell
Mark
McDonnell as
Attorney-in-Fact
*
This Agreement of Joint Filing was executed by Mark McDonnell pursuant
to a Power of Attorney filed as Exhibit 24 and 24.1 to the Form 3 relating to the beneficial ownership of shares of Verve Therapeutics,
Inc. by the Reporting Persons filed with the Securities Exchange Commission on June 16, 2021 and incorporated herein in its entirety by
reference.
Erasca (NASDAQ:ERAS)
Historical Stock Chart
From Oct 2024 to Nov 2024
Erasca (NASDAQ:ERAS)
Historical Stock Chart
From Nov 2023 to Nov 2024